Jump to section
To bring world-class healthcare to everyone.
Patient data is invaluable to clinicians, providing them with past medical information that is essential to inform accurate diagnoses. However, the analysis of this medical data can be time-consuming and this results in non-comprehensive data analysis, with efforts being further strained by administrative duties such as note-taking and missed revenue capturing.
Regard provides an AI-driven medical diagnosis platform, facilitating the automated analysis and synthesis of patient data, diagnoses recommendation, note-taking, and capturing of missed revenue.
Whilst AI-driven medical data analysis platforms are nothing new, Regard stands out by taking a human-interrupted approach to AI, resulting in what is considered an AI clinical assistant as opposed to replacing the work of clinicians. The company claims that its software can save clinicians up to 30% of their time through its automation, whilst improving diagnosis accuracy, reducing coding queries, and improving hospital finances to result in more than $100K in revenue impact per user.
Steph
Company Specialist at Welcome to the Jungle
Jul 2024
$61m
SERIES B
Jun 2022
$15.3m
SERIES A
This company has top investors
Eli Ben-Joseph
(CEO)Experience as Engagement Manager for Applied Predictive Technologies. Teaching Assistant at Stanford University from 2015 to 2016.
Thomas Moulia
(CTO)Experience as Software Engineer for Runway 20, Pocketknife, and Benchling. CTO for HealthTensor from 2016 to 2022.
Nate Wilson
(COO)Experience as Biomedical Research Lead for the University of Virginia. Founder, CEO and Advisor for nData, Inc. from 2014 to 2019.